Pulmonary delivery of insulin by liposomal carriers. J. Control Release. 113: 9-14.
20. Gasco, M.R. (2007) Lipid nanoparticles: perspectives and challenges. Adv. Drug Deliv. Rev. 59: 377-378
21. Wissing, S.A., Kaiser, O. & Müller, R.H. (2004) Solid lipid nanoparticles for parenteral drug delivery. Adv. Drug Deliv. Rev. 56: 131-155.
22. 9.Hu, L., Tang, X. & Cui, F. (2004) Solid Lipid Nanoparticles (SLNs) to improve oral bioavailability of poorly soluble drugs. J. Pharm. Pharmacol. 56: 1527-1535.
23. Videira, M.A., Botelho, M.F., Santos, A.C., Gouveia, L.F., Pedroso de Lima, J.J.& Almeida, A.J. (2002) Pulmonary delivery of SLN as a coloidal drug carriersystem to the lung lymphatics. J. Drug Target. 10: 607-613.
24. García-Fuentes, M., Torres, D. & Alonso, M.J. (2002) Design of lipid nanoparticles for the oral delivery of hydrophilic macromolecules. Coll. Surf. B. Biointerf.27: 159-168